improved release of active pharmaceutical ingredient

Optimizing drug delivery and pharmaceutical formulations is critical for patient compliance and manufacturing efficiency.
Aurorium collaborated with a global specialty pharmaceutical manufacturer to test and improve the release of Active Pharmaceutical Ingredients (API) while reducing production costs.

customer challenge

Specializing in both prescription (Rx) and over-the-counter (OTC) drugs, the specialty manufacturer, sought to:

1. enhance drug release functionality for better patient outcomes.
2. reduce production costs by optimizing formulation efficiency.
3. improve dosage form without compromising therapeutic efficacy.

aurorium’s solution

By integrating Aurorium’s Pharma-K™ Spherical Potassium Chloride (KCl) into the drug formulation, the manufacturer achieved:

• 50% reduction in wax coating, leading to improved release profiles.
• 2x increase in Active Pharmaceutical Ingredient (API) presence, enhancing drug efficacy.
• Streamlined production process, optimizing resource utilization.

proven benefits

• Dosage form optimization: less wax in the pill coating allowed for a higher concentration of API in the formulation.
• Enhanced patient compliance: the new formulation increased patient acceptability and improved the overall consumer experience.
• Manufacturing efficiency: reduced material costs and improved processing efficiency led to lower production expenses.

customer impact

Utilizing Aurorium’s Pharma-K™ KCl, the pharmaceutical manufacturer successfully enhanced drug delivery, reduced production costs, and improved patient compliance. This partnership showcases how formulation advancements can drive both therapeutic and operational success.

future outlook

Aurorium continues to support pharmaceutical partners in advancing API release enhancement, drug formulation, and optimized dosage forms to drive next-generation healthcare solutions.